Superoxide Dismutase Gene Polymorphisms in Patients with Age-related Cataract

REFERENCES

• Davies KJ. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000;50:279–289
   PubMed Web of Science ®Google Scholar
• Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995;17:336–346
   PubMed Web of Science ®Google Scholar
• Spector A, Garner WH. Hydrogen peroxide and human cataract. Experiment Eye Res 1981;33:673–681
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439–1452
   Google Scholar
• Chylack LT Jr., Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49–80
   PubMed Web of Science ®Google Scholar
• Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84–93
   PubMed Web of Science ®Google Scholar
• HapMap-Consortium. The International HapMap Project. Nature 2003;426:789–796
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263–265
   PubMed Web of Science ®Google Scholar
• Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225–2229
   PubMed Web of Science ®Google Scholar
• Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143–149
   PubMedGoogle Scholar
• Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17–32
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 1992;99:546–552
   PubMed Web of Science ®Google Scholar
• Kelly SP, Thornton J, Edwards R, et al. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005;31:2395–2404
   PubMed Web of Science ®Google Scholar
• Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 1997;145:242–249
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research. London, New York: Chapman and Hall; 1991
   Google Scholar
• Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy--Weinberg equilibrium. Am J Human Genet 2005;76:887–893
   PubMed Web of Science ®Google Scholar
• Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921–927
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biologic Chem 1969;244:6049–6055
   PubMed Web of Science ®Google Scholar
• Weisiger RA, Fridovich I. Mitochondrial superoxide dimutase. Site of synthesis and intramitochondrial localization. J Biologic Chem 1973;248:4793–4796
   PubMed Web of Science ®Google Scholar
• Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Nat Acad Sci USA 1982;79:7634–7638
   PubMed Web of Science ®Google Scholar
• Behndig A, Svensson B, Marklund SL, et al. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 1998;39:471–475
   PubMed Web of Science ®Google Scholar
• Rajkumar S, Praveen MR, Gajjar D, et al. Activity of superoxide dismutase isoenzymes in lens epithelial cells derived from different types of age-related cataract. J Cataract Refract Surg 2008;34:470–474
   Google Scholar
• Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319:1429–1433
   PubMed Web of Science ®Google Scholar
• Wang J, Lofgren S, Dong X, et al. Evolution of light scattering and redox balance in the rat lens after in vivo exposure to close-to-threshold dose ultraviolet radiation. Acta Ophthalmol 2010;88:779–785
   Google Scholar
• Lin D, Barnett M, Grauer L, et al. Expression of superoxide dismutase in whole lens prevents cataract formation. Molec Vision 2005;11:853–858
   PubMed Web of Science ®Google Scholar
• Matsui H, Lin LR, Ho YS, et al. The effect of up- and downregulation of MnSOD enzyme on oxidative stress in human lens epithelial cells. Invest Ophthalmol Visual Sci 2003;44:3467–3475
   Google Scholar
• Olofsson EM, Marklund SL, Behndig A. Enhanced age-related cataract in copperzinc superoxide dismutase null mice. Clin Experiment Ophthalmol 2012;40:813–820
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Sun D, et al. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract. Molec Vision 2011;17:2325–2332
   PubMed Web of Science ®Google Scholar
• Huret JL, Delabar JM, Marlhens F, et al. Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality. Hum Genet 1987;75:251–257
   Google Scholar
• Krawczak M, Cooper DN. The human gene mutation database. Trends Genet 1997;13:121–122
   PubMed Web of Science ®Google Scholar
• Pagano G, Castello G. Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Experiment Med Biol 2012;724:291–299
   PubMed Web of Science ®Google Scholar
• Kowald A, Klipp E. Alternative pathways might mediate toxicity of high concentrations of superoxide dismutase. Ann NY Acad Sci 2004;1019:370–374
   PubMed Web of Science ®Google Scholar
• Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus 2009;46:76–82
   PubMed Web of Science ®Google Scholar
• Al-Kateb H, Boright AP, Mirea L, et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 2008;57:218–228
   PubMedGoogle Scholar
• Mohammedi K, Maimaitiming S, Emery N, et al. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab 2011;104:654–660
   Google Scholar
• Panduru NM, Cimponeriu D, Cruce M, et al. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes. Rom J Morphol Embryol 2010;51:37–41
   PubMed Web of Science ®Google Scholar
• Hendrickson DJ, Fisher JH, Jones C, et al. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics 1990;8:736–738
   Google Scholar
• Sandstrom J, Nilsson P, Karlsson K, et al. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biologic Chem 1994;269:19163–19166
   PubMed Web of Science ®Google Scholar
• Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Nat Acad Sci USA 1996;93:4471–4473
   PubMed Web of Science ®Google Scholar
• Church SL, Grant JW, Meese EU, et al. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 1992;14:823–825
   Google Scholar
• Hiroi S, Harada H, Nishi H, et al. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Bioph Res Co 1999;261:332–339
   PubMed Web of Science ®Google Scholar
• Wang LI, Miller DP, Sai Y, et al. Manganese superoxide dismutase alanine-tovaline polymorphism at codon 16 and lung cancer risk. J Nat Cancer Institute 2001;93:1818–1821
   PubMed Web of Science ®Google Scholar
• Wiener HW, Perry RT, Chen Z, et al. A polymorphism in SOD2 is associated with development of Alzheimer’s disease. Genes Brain Behav 2007;6:770–775
   PubMed Web of Science ®Google Scholar
• Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. Biochem Bioph Res Co 1996;226:561–565
   PubMed Web of Science ®Google Scholar
• Ergen HA, Narter F, Timirci O, et al. Effects of manganese superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study. Anticancer Res 2007;27:1227–1230
   PubMed Web of Science ®Google Scholar
• Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602–606
   PubMed Web of Science ®Google Scholar
• Soerensen M, Christensen K, Stevnsner T, et al. The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev 2009;130:308–314
   PubMed Web of Science ®Google Scholar